Investigational drugs; expanded access. (HB1750)
Introduced By
Del. Margaret Ransone (R-Kinsale) with support from 17 copatrons, whose average partisan position is:
Those copatrons are Del. Dave Albo (R-Springfield), Del. Mark Cole (R-Fredericksburg), Del. Gordon Helsel (R-Poquoson), Del. Patrick Hope (D-Arlington), Del. Bill Howell (R-Fredericksburg), Del. Matthew James (D-Portsmouth), Del. Mark Keam (D-Vienna), Del. Randy Minchew (R-Leesburg), Del. Bobby Orrock (R-Thornburg), Del. John O'Bannon (R-Richmond), Del. Chris Peace (R-Mechanicsville), Del. David Ramadan (R-South Riding), Del. Roxann Robinson (R-Chesterfield), Del. Mark Sickles (D-Alexandria), Del. Chris Stolle (R-Virginia Beach), Del. Tony Wilt (R-Harrisonburg), Sen. Todd E. Pillion (R-Abingdon)
Progress
✓ |
Introduced |
✓ |
Passed Committee |
✓ |
Passed House |
✓ |
Passed Senate |
✓ |
Signed by Governor |
☐ |
Became Law |
Description
Expanded access to investigational drugs, biological products, and devices. Provides that a manufacturer of an investigational drug, biological product, or device may make such investigational drug, biological product, or device available to a person who has a terminal illness when (i) no comparable or satisfactory alternative treatment options approved by the U.S. Food and Drug Administration are available to treat his terminal illness; (ii) the potential benefits of the use of the investigational drug, biological product, or device outweigh the risks of use of the investigational drug, biological product, or device; (iii) his treating physician has recommended use of the investigational drug, biological product, or device; and (iv) the person has provided informed written consent to use of the investigational drug, biological product, or device. The bill provides that a manufacturer that provides an investigational drug, biological product, or device for treatment of a person's terminal illness may provide the investigational drug, biological product, or device free of charge or may require the person to pay costs associated with manufacture of the investigational drug, biological product, or device. The bill also provides that health insurance providers may, but are not required to, provide coverage for costs associated with use of the investigational drug, biological product, or device. Read the Bill »
Outcome
History
Date | Action |
---|---|
01/12/2015 | Committee |
01/12/2015 | Prefiled and ordered printed; offered 01/14/15 15100033D |
01/12/2015 | Referred to Committee on Health, Welfare and Institutions |
01/20/2015 | Assigned HWI sub: Subcommittee #1 |
01/26/2015 | Subcommittee recommends reporting with amendment(s) (11-Y 0-N) |
01/28/2015 | Impact statement from VDH (HB1750) |
01/29/2015 | Reported from Health, Welfare and Institutions with amendments (22-Y 0-N) (see vote tally) |
01/30/2015 | Read first time |
02/02/2015 | Read second time |
02/02/2015 | Committee amendments agreed to |
02/02/2015 | Engrossed by House as amended HB1750E |
02/02/2015 | Printed as engrossed 15100033D-E |
02/03/2015 | Impact statement from VDH (HB1750E) |
02/03/2015 | Read third time and passed House BLOCK VOTE (98-Y 0-N) |
02/03/2015 | VOTE: BLOCK VOTE PASSAGE (98-Y 0-N) (see vote tally) |
02/04/2015 | Constitutional reading dispensed |
02/04/2015 | Referred to Committee on Education and Health |
02/19/2015 | Reported from Education and Health with substitute (14-Y 0-N) (see vote tally) |
02/19/2015 | Committee substitute printed 15105265D-S1 |
02/20/2015 | Impact statement from VDH (HB1750S1) |
02/20/2015 | Constitutional reading dispensed (38-Y 0-N) (see vote tally) |
02/23/2015 | Read third time |
02/23/2015 | Reading of substitute waived |
02/23/2015 | Committee substitute agreed to 15105265D-S1 |
02/23/2015 | Passed by for the day |
02/24/2015 | Read third time |
02/24/2015 | Engrossed by Senate - committee substitute HB1750S1 |
02/24/2015 | Passed Senate with substitute (39-Y 0-N) (see vote tally) |
02/24/2015 | Placed on Calendar |
02/25/2015 | Senate substitute agreed to by House 15105265D-S1 (98-Y 0-N) |
02/25/2015 | VOTE: ADOPTION (98-Y 0-N) (see vote tally) |
03/06/2015 | Enrolled |
03/06/2015 | Bill text as passed House and Senate (HB1750ER) |
03/06/2015 | Impact statement from VDH (HB1750ER) |
03/06/2015 | Signed by Speaker |
03/07/2015 | Signed by President |
03/10/2015 | Enrolled Bill communicated to Governor on 3/10/15 |
03/10/2015 | G Governor's Action Deadline Midnight, Sunday, March 29, 2015 |
03/26/2015 | G Approved by Governor-Chapter 656 (effective 7/1/15) |
03/26/2015 | G Acts of Assembly Chapter text (CHAP0656) |